Clinical Trials for EGFR L861Q

Find clinical trials for egfr l861q. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations

NCT ID: NCT06517953

This clinical trial is investigating the use of two targeted drugs, Befotertinib and Icotinib, as a first-line treatment for patients with non-small cell lung cancer (NSCLC) who have uncommon mutat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation

NCT ID: NCT05548348

This clinical trial is exploring a new treatment called furmonertinib for patients with advanced non-small cell lung cancer (NSCLC) who have specific genetic mutations known as EGFR G719X, L861Q, o...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chongqing, Chongqing, China, Chongqing, Chongqing, China +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions